Political Analyst

Among Democrats and Democratic leaners, 32 percent say Democrats are the party with strong leaders. I mean, of their own kind, right?

Among Democrats and Democratic leaners, 32 percent say Democrats are the party with strong leaders. I mean, of their own kind, right?

Among Democrats and Democratic leaners, 32 percent say Democrats are the party with strong leaders. I mean, of their own kind, right?

This, I think, is the most fascinating. How do partisans talk about their own party? So among Democrats and Democratic leaners, 32% say Democrats are the party with strong leaders. I mean, of their own kind, right? 82% of Republican or Republican leaders say that about the GOP. Only 41% of Democrats say they're the party that gets things done of their own kind.

This, I think, is the most fascinating. How do partisans talk about their own party? So among Democrats and Democratic leaners, 32% say Democrats are the party with strong leaders. I mean, of their own kind, right? 82% of Republican or Republican leaders say that about the GOP. Only 41% of Democrats say they're the party that gets things done of their own kind.

This, I think, is the most fascinating. How do partisans talk about their own party? So among Democrats and Democratic leaners, 32% say Democrats are the party with strong leaders. I mean, of their own kind, right? 82% of Republican or Republican leaders say that about the GOP. Only 41% of Democrats say they're the party that gets things done of their own kind.

And I will just say, 51%, Manu, a majority of Democratic and Democratic leaners say neither party gets the party that gets things done attribute. Imagine that is the whole, that's the project that Democrats are working on.

And I will just say, 51%, Manu, a majority of Democratic and Democratic leaners say neither party gets the party that gets things done attribute. Imagine that is the whole, that's the project that Democrats are working on.

And I will just say, 51%, Manu, a majority of Democratic and Democratic leaners say neither party gets the party that gets things done attribute. Imagine that is the whole, that's the project that Democrats are working on.

I think it speaks to a bigger challenge for Democrats. They have spent the last eight years being the party that is the anti-Trump party. They haven't been the party that is the pro-fill-in-the-blank party. So they've been very much defined by Donald Trump, not defined by what they want to be.

I think it speaks to a bigger challenge for Democrats. They have spent the last eight years being the party that is the anti-Trump party. They haven't been the party that is the pro-fill-in-the-blank party. So they've been very much defined by Donald Trump, not defined by what they want to be.

I think it speaks to a bigger challenge for Democrats. They have spent the last eight years being the party that is the anti-Trump party. They haven't been the party that is the pro-fill-in-the-blank party. So they've been very much defined by Donald Trump, not defined by what they want to be.

In the U.K., the government buys the stock of medicine for the country. That means they're usually able to get a lower rate, kind of like a bulk discount. In almost every developed country besides the U.S., this is what the system looks like. Safety evaluation, assessment of whether the country needs it, price negotiations, sold to patients. Now let's look at the system in the United States.

In the U.K., the government buys the stock of medicine for the country. That means they're usually able to get a lower rate, kind of like a bulk discount. In almost every developed country besides the U.S., this is what the system looks like. Safety evaluation, assessment of whether the country needs it, price negotiations, sold to patients. Now let's look at the system in the United States.

In the U.K., the government buys the stock of medicine for the country. That means they're usually able to get a lower rate, kind of like a bulk discount. In almost every developed country besides the U.S., this is what the system looks like. Safety evaluation, assessment of whether the country needs it, price negotiations, sold to patients. Now let's look at the system in the United States.

First, the drug is evaluated for safety. But that's it. If it's safe, they can sell it. End of story. Drugs are sold by the drug companies to patients, usually through insurance. Regulated drug markets tend to make drugs more affordable, but some drugs are completely unavailable. And while the U.S. has more drugs technically available, they're often too expensive to actually afford.

First, the drug is evaluated for safety. But that's it. If it's safe, they can sell it. End of story. Drugs are sold by the drug companies to patients, usually through insurance. Regulated drug markets tend to make drugs more affordable, but some drugs are completely unavailable. And while the U.S. has more drugs technically available, they're often too expensive to actually afford.

First, the drug is evaluated for safety. But that's it. If it's safe, they can sell it. End of story. Drugs are sold by the drug companies to patients, usually through insurance. Regulated drug markets tend to make drugs more affordable, but some drugs are completely unavailable. And while the U.S. has more drugs technically available, they're often too expensive to actually afford.

Mr. President, what do you say to people who view that luxury jet as a personal gift to you? Why not leave it behind?

Mr. President, what do you say to people who view that luxury jet as a personal gift to you? Why not leave it behind?